Search Result
PGNY | Progyny Inc Progyny, Inc.
You can also get more PGNY info from:
MarketWatch
CNBC
SeekingAlpha
Y!Finance
BarChart
Zacks
TheStreet
QuoteMedia
FinViz
Benzinga
StockTwits
Ycharts
GuruFocus
StockAnalysis
MarketBeat
美股之家
StreetInsider
雪球
Tiingo
Stocks Trading Charts
WSJ
TradingView
Martkets Insider
Robinhood
OTC Markets
Chartmill
Barrons
MarketChameleon
Stocklight
StockMarketWatch
Stockhouse
TD Ameritrade
TalkMarkets
Stocknews
Tipranks
InvestorsObserver
RealMoney
StockConsultant
Stockinvest
Investorplace
Swingtradebot
WalletInvestor
DividendInvestor
Dogsofthedow
Echofin
TradingEconomics
Polygon
Equities
Fidelity
StockInvestor
Fintel
EarningsWhispers
StockMonitor
InvestingPort
Whotrades
CapitalMarketLaboratories
FinancialContent
TMX Money
Stocks2
Trade-ideas
InsiderTracking
Kiplinger
CNN
SEC Fillings
WhaleWisdom
iBorrowDesk
雪球
Webb-Site
MG21
MG21
Y!Finance Chart
WhaleWisdom
MacroAxis
OutstandingSharesRecord
HoldingsChannel
StratoSphere
MyTrack
Result:1
Result:1
PGNY | Progyny Inc
|
Market Value: $3.41 Billion
Shares: 92,080,926
52-Week Range: 26-68
PS Ratio Estimate: 7.0 (based on most recent quarter revenue x 4)
CRG Score: 2
Market Value: $3.41 Billion
Shares: 92,080,926
52-Week Range: 26-68
PS Ratio Estimate: 7.0 (based on most recent quarter revenue x 4)
CRG Score: 2
IPO: 2019-10-25
Year Founded: 2008-04-03
Core Business: Progyny, Inc. is a medical device company. It engages in the field of reproductive medicine, translating scientific discoveries related to early embryo development into clinical tools. The firm operates through the following segments: medical device and fertility benefits solution. The company's services include egg freezing, IVF treatment, surrogacy, podcast, adoption, and Eeva Test.